Hexagon Bio leverages a genomics-based platform to develop next-generation antibody-drug conjugates (ADCs) that feature novel payloads for cancer treatment. By integrating data science, genomics, and machine learning, the company discovers and optimizes potent small molecules derived from microbial genomes, positioning itself at the forefront of innovative cancer therapeutics.
No jobs found. Subscribe below to get notified when we find something for you.
Searching